AdvanSix Inc. (ASIX)
NYSE: ASIX
· Real-Time Price · USD
19.61
0.18 (0.93%)
At close: Sep 24, 2025, 3:59 PM
19.61
0.00%
After-hours: Sep 24, 2025, 05:51 PM EDT
AdvanSix Revenue Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Caprolactam Revenue | 66.42M | 67.43M | 57.19M | 76.34M | 81.3M | 61.48M | 82.51M | 68.79M | 74.68M | 72.39M | 71.87M | 90.82M | 87.17M | 70M | 235.87M | 80.27M |
| Caprolactam Revenue Growth | -1.49% | +17.92% | -25.09% | -6.11% | +32.25% | -25.49% | +19.94% | -7.88% | +3.17% | +0.72% | -20.86% | +4.19% | +24.52% | -70.32% | +193.86% | n/a |
| Chemical Intermediates Revenue | 107.33M | 93.75M | 79.13M | 120.49M | 129.28M | 105.7M | 118.29M | 83.46M | 121.36M | 114.56M | 101.95M | 115.27M | 158.61M | 135.69M | 413.58M | 130.92M |
| Chemical Intermediates Revenue Growth | +14.48% | +18.48% | -34.33% | -6.80% | +22.31% | -10.64% | +41.73% | -31.23% | +5.94% | +12.38% | -11.56% | -27.33% | +16.89% | -67.19% | +215.91% | n/a |
| Nylon Resins Revenue | 79.5M | 88.37M | 67.2M | 93.69M | 103.22M | 84.39M | 78.25M | 86.06M | 92.95M | 99.37M | 93.51M | 141.02M | 132.1M | 118.61M | 300.79M | 122.11M |
| Nylon Resins Revenue Growth | -10.03% | +31.50% | -28.27% | -9.23% | +22.31% | +7.84% | -9.07% | -7.42% | -6.46% | +6.27% | -33.69% | +6.75% | +11.38% | -60.57% | +146.32% | n/a |
Revenue by Geography
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Us Revenue | 51.35M | 57.34M | 50.43M | 58.29M | 51.62M | 52.24M | 85.51M | 58.05M | 60.33M | 79.62M | 72.15M | 85.32M | 89.58M | 76.06M | 80.86M | 81.28M | 64.27M | 75.71M | 73.17M | 64.85M | 56.71M | 72.27M | 60.58M | 55.66M | 57.25M | 61.84M | 62.6M | 57.96M | 61.59M |
| Non-Us Revenue Growth | -10.45% | +13.71% | -13.48% | +12.93% | -1.19% | -38.90% | +47.30% | -3.78% | -24.22% | +10.36% | -15.44% | -4.75% | +17.78% | -5.94% | -0.53% | +26.47% | -15.11% | +3.47% | +12.84% | +14.35% | -21.53% | +19.30% | +8.83% | -2.78% | -7.43% | -1.21% | +8.01% | -5.89% | n/a |
| United States Revenue | 358.67M | 320.45M | 278.63M | 339.89M | 401.86M | 284.59M | 296.7M | 264.86M | 367.61M | 320.93M | 331.92M | 393.45M | 494.15M | 403.02M | 343.21M | 365.21M | 373.41M | 300.67M | 267.18M | 217.06M | 176.31M | 230.44M | 250.06M | 289.55M | 257.64M | 324.81M | 306.05M | 342.5M | 297.65M |
| United States Revenue Growth | +11.93% | +15.01% | -18.02% | -15.42% | +41.21% | -4.08% | +12.02% | -27.95% | +14.55% | -3.31% | -15.64% | -20.38% | +22.61% | +17.43% | -6.02% | -2.20% | +24.19% | +12.53% | +23.09% | +23.11% | -23.49% | -7.84% | -13.64% | +12.39% | -20.68% | +6.13% | -10.64% | +15.07% | n/a |
Operating Expense Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 25.42M | 23.41M | 21.73M | 24.27M | 24.43M | 23.59M | 24.83M | 21.59M | 24.01M | 25.11M | 22.63M | 23.07M | 20.84M | 21.21M | 20.87M | 21.12M | 21.68M | 19.31M | 20.04M | 16.18M | 17.91M | 16.74M | 16.69M | 19.26M | 20.01M | 19.41M | 26.04M | 18.06M | 17.92M | 19.21M | 18.79M | 19.09M | 18.13M | 16.81M | 19.8M | 11.7M | 10.88M | 11.38M | 13.19M | 14.61M | 13.21M | 11.39M |
| Selling, General, and Administrative Revenue Growth | +8.57% | +7.71% | -10.43% | -0.68% | +3.55% | -4.97% | +15.02% | -10.10% | -4.39% | +10.99% | -1.91% | +10.69% | -1.74% | +1.61% | -1.17% | -2.59% | +12.30% | -3.66% | +23.89% | -9.68% | +7.00% | +0.29% | -13.34% | -3.74% | +3.07% | -25.43% | +44.18% | +0.77% | -6.74% | +2.24% | -1.54% | +5.27% | +7.88% | -15.14% | +69.34% | +7.53% | -4.42% | -13.76% | -9.69% | +10.61% | +15.99% | n/a |
| Research and Development Revenue | n/a | n/a | 8.8M | n/a | n/a | n/a | 9.8M | n/a | n/a | n/a | 12.5M | n/a | n/a | n/a | 14M | n/a | n/a | n/a | 11.8M | n/a | n/a | n/a | 13.9M | n/a | n/a | n/a | 14.8M | n/a | n/a | n/a | 12.9M | n/a | n/a | n/a | 13.76M | n/a | n/a | n/a | 12.81M | n/a | n/a | n/a |
| Research and Development Revenue Growth | n/a | -100.00% | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | n/a |